Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's ...
We recently published a list of Jim Cramer Says You Should Buy These 10 Stocks. Since Eli Lilly & Co (NYSE:LLY) ranks 3rd on ...
The new drug, Kisunla, has the potential to be a blockbuster for the company and generate billions in revenue. But despite ...
Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced ...
Several other top trending stocks on the Yahoo Finance platform include Paramount Global (PARA) as the media company agrees to an $8 billion merger with Skydance Media; Eli Lilly (LLY) $3.2 ...
Compared to its industry, the company has lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of ...
Eli Lilly, with a market value of nearly $900 billion, has vaulted past Tesla into the top 10 list of U.S. companies.
The acquisition bolsters Lilly's gastroenterology portfolio, with a focus on developing new treatments for inflammatory bowel ...
Pfizer is also benefiting from its Seagen acquisition, which is expected to add $10 billion to the company’s top-line by ...
Opinion: Indianapolis' poverty level could be addressed if we got back what is given to the billion-dollar drug manufacturer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback